Roche and Tamiflu®: Doing Business in the Shadow of Pandemic

Kellogg School of Management Cases

ISSN: 2474-6568

Publication date: 20 January 2017


Students will weigh the benefits of short-term profit maximization against the risks that a highly uncertain event could pose to a business and consider nonstandard approaches to mitigate these risks. Students will discuss the challenges of addressing low-probability, high-impact events; potential conflicts with the short-term view of the stock market and analyst community; and challenges of the patent protection model for drugs for life-threatening diseases.



Feddersen, T., Gottschalk, J. and Peters, L. (2017), "Roche and Tamiflu®: Doing Business in the Shadow of Pandemic", Kellogg School of Management Cases.

Download as .RIS



Kellogg School of Management

Copyright © 2007, The Kellogg School of Management at Northwestern University

Please note you might not have access to this content

You may be able to access this content by login via Shibboleth, Open Athens or with your Emerald account.
If you would like to contact us about accessing this content, click the button and fill out the form.